Covid-19 vaccine: Bharat Biotech’s Covaxin shows 77.8% efficacy against Covid, says Lancet

0
14

The company has manufactured and supplied 150 million doses of Covaxin, and said it will achieve an annualised capacity of one billion doses by 2021-end.